CSIMarket
 
Satellos Bioscience Inc   (MSLE)
 

Satellos Bioscience Inc's Customers Performance

MSLE



 
MSLE's Source of Revenues

• List of MSLE Customers




for the same period Satellos Bioscience Inc

• List of MSLE Customers





Satellos Bioscience Inc's Comment on Sales, Marketing and Customers



Satellos focuses on the research and development of novel therapeutics for life-threatening diseases, aiming to have its products approved and registered for sale globally. The company operates through subsidiaries including Satellos Bioscience Australia Pty Ltd and Satellos Bioscience US, Inc. Following a business combination with iCo, Satellos acquired assets such as Amphotericin B Technologies Inc. (Amp B) to support its strategy of creating value and attracting partnerships or funding. NW Micelle Therapeutics Inc. (NWMT) was established with NW PharmaTech holding an 85% stake and Amp B holding 15%. Subsequently, Amphotericin B Technologies Inc. was sold to Natural Works Trading Limited as part of a strategic portfolio adjustment.





Satellos Bioscience Inc’s Comment on Sales, Marketing and Customers


Satellos focuses on the research and development of novel therapeutics for life-threatening diseases, aiming to have its products approved and registered for sale globally. The company operates through subsidiaries including Satellos Bioscience Australia Pty Ltd and Satellos Bioscience US, Inc. Following a business combination with iCo, Satellos acquired assets such as Amphotericin B Technologies Inc. (Amp B) to support its strategy of creating value and attracting partnerships or funding. NW Micelle Therapeutics Inc. (NWMT) was established with NW PharmaTech holding an 85% stake and Amp B holding 15%. Subsequently, Amphotericin B Technologies Inc. was sold to Natural Works Trading Limited as part of a strategic portfolio adjustment.








MSLE's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Satellos Bioscience Inc 127.35 0.00 -24.87 -
SUBTOTAL 0.00 0.00 0.00 -

Sources: Satellos Bioscience Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Satellos Bioscience Inc’s corporate clients.
For your research, we’ve provided 9 tables on Satellos Bioscience Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.